非甾体抗炎药诱导的小肠损伤与益生菌制剂。
Non-steroidal anti-inflammatory drugs-induced small intestinal injury and probiotic agents.
出版信息
World J Gastroenterol. 2012 Aug 21;18(31):4241-2. doi: 10.3748/wjg.v18.i31.4241.
Abstract
Intestinal bacteria play a role in the development of non-steroidal anti-inflammatory drugs (NSAID)-induced small intestinal injury. Agents such as probiotics, able to modify the gut ecology, might theoretically be useful in preventing small intestinal damage induced by NSAIDs. The clinical studies available so far do suggest that some probiotic agents can be effective in this respect.
摘要
肠道细菌在非甾体抗炎药（NSAID）诱导的小肠损伤的发展中起作用。益生菌等能够改变肠道生态的药物，理论上可能有助于预防 NSAID 引起的小肠损伤。到目前为止，现有的临床研究表明，一些益生菌制剂在这方面可能是有效的。
相似文献
1
Non-steroidal anti-inflammatory drugs-induced small intestinal injury and probiotic agents.非甾体抗炎药诱导的小肠损伤与益生菌制剂。
World J Gastroenterol. 2012 Aug 21;18(31):4241-2. doi: 10.3748/wjg.v18.i31.4241.
2
Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury.非甾体抗炎药诱导的小肠损伤的预防和治疗。
World J Gastroenterol. 2011 Nov 14;17(42):4647-53. doi: 10.3748/wjg.v17.i42.4647.
3
Prevention of traditional NSAID-induced small intestinal injury: recent preliminary studies using capsule endoscopy.预防传统 NSAID 引起的小肠损伤：胶囊内镜的最新初步研究。
Digestion. 2010;82(3):167-72. doi: 10.1159/000308361. Epub 2010 Jun 25.
4
NSAID enteropathy: could probiotics prevent it?非甾体抗炎药相关性肠病：益生菌能预防它吗？
J Gastroenterol. 2013 Jun;48(6):689-97. doi: 10.1007/s00535-012-0648-2. Epub 2012 Aug 9.
5
Long-Term Outcomes of NSAID-Induced Small Intestinal Injury Assessed by Capsule Endoscopy in Korea: A Nationwide Multicenter Retrospective Study.韩国通过胶囊内镜评估非甾体抗炎药所致小肠损伤的长期结局：一项全国多中心回顾性研究
Gut Liver. 2015 Nov 23;9(6):727-33. doi: 10.5009/gnl14134.
6
Anti-tumour necrosis factor agents reduce non-steroidal anti-inflammatory drug-induced small bowel injury in rheumatoid arthritis patients.抗肿瘤坏死因子制剂可减少类风湿关节炎患者中 NSAIDs 诱导的小肠损伤。
Gut. 2014 Mar;63(3):409-14. doi: 10.1136/gutjnl-2013-304713. Epub 2013 May 22.
7
Preventing nonsteroidal anti-inflammatory drug-induced small-bowel injury: the saga continues.预防非甾体抗炎药引起的小肠损伤：故事仍在继续。
Gastrointest Endosc. 2009 Jun;69(7):1347-9. doi: 10.1016/j.gie.2008.10.014.
8
Management of NSAID/aspirin-induced small intestinal damage by GI-sparing NSAIDs, anti-ulcer drugs and food constituents.通过胃肠道保护型 NSAIDs、抗溃疡药物和食物成分来管理 NSAID/阿司匹林引起的小肠损伤。
Curr Med Chem. 2012;19(1):82-9. doi: 10.2174/092986712803413980.
9
Distribution of small intestinal mucosal injuries as a result of NSAID administration.非甾体抗炎药导致的小肠黏膜损伤分布情况。
Eur J Clin Invest. 2010 Jun;40(6):504-10. doi: 10.1111/j.1365-2362.2010.02290.x. Epub 2010 Apr 14.
10
Microbiota Plays a Key Role in Non-Steroidal Anti-Inflammatory Drug-Induced Small Intestinal Damage.微生物群在非甾体抗炎药引起的小肠损伤中起关键作用。
Digestion. 2017;95(1):22-28. doi: 10.1159/000452356. Epub 2017 Jan 5.
引用本文的文献
1
Gut Microbiota in NSAID Enteropathy: New Insights From Inside.肠内菌群与 NSAID 肠病：来自内部的新见解。
Front Cell Infect Microbiol. 2021 Jul 6;11:679396. doi: 10.3389/fcimb.2021.679396. eCollection 2021.
2
Understanding and modulating mammalian-microbial communication for improved human health.理解并调节哺乳动物与微生物之间的交流以促进人类健康。
Annu Rev Pharmacol Toxicol. 2014;54:559-80. doi: 10.1146/annurev-pharmtox-011613-140007. Epub 2013 Oct 23.
本文引用的文献
1
Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury.非甾体抗炎药诱导的小肠损伤的预防和治疗。
World J Gastroenterol. 2011 Nov 14;17(42):4647-53. doi: 10.3748/wjg.v17.i42.4647.
2
Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis.质子泵抑制剂通过诱导菌群失调加剧 NSAID 引起的小肠损伤。
Gastroenterology. 2011 Oct;141(4):1314-22, 1322.e1-5. doi: 10.1053/j.gastro.2011.06.075. Epub 2011 Jul 13.
3
Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study.酪酸梭菌治疗慢性低剂量阿司匹林使用者小肠损伤的疗效：一项初步随机对照研究。
J Gastroenterol. 2011 Jul;46(7):894-905. doi: 10.1007/s00535-011-0410-1. Epub 2011 May 10.
4
Clinical trial: the effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy - a randomized, double-blind, cross-over, placebo-controlled study.临床试验：益生菌混合物对非甾体抗炎药肠病的影响 - 一项随机、双盲、交叉、安慰剂对照研究。
Aliment Pharmacol Ther. 2010 Jul;32(2):209-14. doi: 10.1111/j.1365-2036.2010.04324.x. Epub 2010 Apr 7.
5
Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid.益生菌干酪乳杆菌Shirota菌株可预防吲哚美辛诱导的小肠损伤：乳酸的作用。
Am J Physiol Gastrointest Liver Physiol. 2009 Sep;297(3):G506-13. doi: 10.1152/ajpgi.90553.2008. Epub 2009 Jul 9.
6
NSAID-induced intestinal damage: are luminal bacteria the therapeutic target?非甾体抗炎药引起的肠道损伤：管腔内细菌是治疗靶点吗？
Gut. 2008 Feb;57(2):145-8. doi: 10.1136/gut.2007.134502.
7
Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans.摄入乳酸杆菌对消炎痛诱导的人体胃肠道黏膜屏障改变的影响。
Aliment Pharmacol Ther. 2001 Jan;15(1):11-7. doi: 10.1046/j.1365-2036.2001.00898.x.
Zotero 插件